Improving Oxygenation by the Intravenous Route

Tunnicliffe FW , Stebbing GF . Intravenous injection of oxygen gas as a therapeutic measure. Lancet 1916; 2:321–323.

Bourne G , Smith RG . The value of intravenous and intraperitoneal administration of oxygen. Am J Physiol 1927;82:328–334.

Schmidt PJ , Holland PV . Pathogenesis of the acute renal failure associated with incompatible transfusion. Lancet 1967;2:1169–1172.

Birndorf NI , Lopas H. Effect of red cell stroma-free hemoglobin solution on renal function in monkeys. J Appl Physiol 1970;29:573–578.

DeVenuto F , Zuck TF , Zegna AI , . Characteristics of stroma-free hemoglobin prepared by crystallization. J Lab Clin Med 1977;89:509–516.

DeVenuto F. Hemoglobin solutions as oxygen-delivering resuscitation fluids. Crit Care Med 1982;10:238–245.

Scannon PJ . Molecular modifications of hemoglobin. Crit Care Med 1982; 10:261–265.

Jesch FH , Peters W , Hobbhahn J , Schoenberg M , Messmer K. Oxygen-transporting fluids and oxygen delivery with hemodilution. Crit Care Med 1982;10:270–274.

Busch DH . Chelate compounds as components of acellular, oxygen-delivering resuscitation fluids. Crit Care Med 1982;10:246–253.

Geyer RP , Monroe RG , Taylor K. Survival of rats having red cells totally replaced with emulsified fluorocarbon (abstract). Fed Proc 1968;27:384.

Geyer RP . "Bloodless" rats through the use of artificial blood substitutes. Fed Proc 1975;34:1499–1505.

Naito R , Yokoyama K. Supplement to PFC blood substitutes (FC-43 emulsion, Fluosol-DA 20% and 35%) as an oxygen-carrying colloidal blood substitute. Osaka, Japan: Green Cross Technical Information Service, Publication No. 7, July 30, 1981.

Makowski H , Tentschev P , Frey R , Necek ST , Bergmann H , Blauhut B. Tolerance of an oxygen-carrying colloidal plasma substitute in human beings. Proceedings on the IVth International Symposium on PFCB Subst, Kyoto, Japan, October, 1978. Amsterdam: Excerpta Medica, 1979:47–54.

Ohyanagi H , Toshima K , Sekita M , . Clinical studies of perfluorochemical whole blood substitutes: Safety of Fluosol-DA (20%) in normal human volunteers. Clin Ther 1979;2:306–312.

Tremper KK , Friedman AE , Levine EM , Lapin R , Camarillo D. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA. N Engl J Med 1982; 307:277–283.

Geyer RP . Oxygen transport in vivo by means of perfluorochemical preparations (editorial). N Engl J Med 1982;307:304–305.